Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Lothe IMB"'
Autor:
Elvebakken H; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway. Hege.Elvebakken@helse-mr.no.; Department of Oncology, Ålesund Hospital, Møre and Romsdal Hospital Trust, Ålesund, Norway. Hege.Elvebakken@helse-mr.no., Venizelos A; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway., Perren A; Institute of Tissue Medicine and Pathology, University of Bern, Bern, Switzerland., Couvelard A; Department of Pathology, Université Paris Cité and AP-HP, Bichat Hospital, Paris, France., Lothe IMB; Department of Pathology, Oslo University Hospital, Oslo, Norway., Hjortland GO; Department of Oncology, Oslo University Hospital, Oslo, Norway., Myklebust TÅ; Department of Research and Innovation, Møre and Romsdal Hospital Trust, Ålesund, Norway.; Department of Registration, Cancer Registry Norway, Oslo, Norway., Svensson J; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden., Garresori H; Department of Oncology, Stavanger University Hospital, Stavanger, Norway., Kersten C; Department of Research, Hospital of Southern Norway, Kristiansand, Norway., Hofsli E; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Oncology, St.Olavs Hospital, Trondheim, Norway., Detlefsen S; Department of Pathology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark., Vestermark LW; Danish Medicines Agency, Copenhagen, Denmark., Knappskog S; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Bergen, Norway., Sorbye H; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway.
Publikováno v:
British journal of cancer [Br J Cancer] 2024 Sep; Vol. 131 (4), pp. 676-684. Date of Electronic Publication: 2024 Jun 22.
Autor:
Venizelos A; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Bergen, Norway., Sorbye H; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway., Elvebakken H; Department of Oncology, Ålesund Hospital, Møre og Romsdal Hospital Trust, Ålesund, Norway.; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway., Perren A; Institute of Tissue Medicine and Pathology, University of Bern, Bern, Switzerland., Lothe IMB; Department of Pathology, Oslo University Hospital, Oslo, Norway., Couvelard A; Department of Pathology, Université Paris Cité and AP-HP, Bichat Hospital, Paris, France., Hjortland GO; Department of Oncology, Oslo University Hospital, Oslo, Norway., Sundlöv A; Departmentt of Oncology, Skåne University Hospital, Lund, Sweden.; Department of Medical Radiation Physics, Lund University, Lund, Sweden., Svensson J; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden., Garresori H; Department of Oncology, Stavanger University Hospital, Stavanger, Norway., Kersten C; Department of Research, Hospital of Southern Norway, Kristiansand, Norway., Hofsli E; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Oncology, St. Olavs Hospital, Trondheim, Norway., Detlefsen S; Department of Pathology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark., Vestermark LW; Department of Oncology, Odense University Hospital, Odense, Denmark., Ladekarl M; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.; Department of Oncology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark., Tabaksblat EM; Department of Oncology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark., Knappskog S; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Bergen, Norway.
Publikováno v:
Endocrine-related cancer [Endocr Relat Cancer] 2023 Aug 23; Vol. 30 (10). Date of Electronic Publication: 2023 Aug 23 (Print Publication: 2023).
Autor:
Elvebakken H; Department of Oncology, Ålesund Hospital, Møre og Romsdal Hospital Trust, Ålesund, Norway.; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway., Hjortland GO; Department of Oncology, Oslo University Hospital, Oslo, Norway., Garresori H; Department of Haematology and Oncology, Stavanger University Hospital, Stavanger, Norway., Andresen PA; Department of Pathology, Oslo University Hospital, Oslo, Norway., Janssen EAM; Department of Pathology, Stavanger University Hospital, Stavanger, Norway.; Department of Chemistry, Bioscience and Environmental Engineering, Stavanger University, Stavanger, Norway., Vintermyr OK; Department of Pathology, Haukeland University Hospital, Bergen, Norway., Lothe IMB; Department of Pathology, Oslo University Hospital, Oslo, Norway., Sorbye H; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway.
Publikováno v:
Journal of neuroendocrinology [J Neuroendocrinol] 2023 Apr; Vol. 35 (4), pp. e13256. Date of Electronic Publication: 2023 Apr 05.
Autor:
Silwal-Pandit L; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Stålberg SM; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Natural Sciences and Environmental Health, University of South-Eastern Norway, Bø i Telemark, Norway., Johansson HJ; Department of Oncology-Pathology, Karolinska Institutet, Science for Life Laboratory, Solna, Sweden., Mermelekas G; Department of Oncology-Pathology, Karolinska Institutet, Science for Life Laboratory, Solna, Sweden., Lothe IMB; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Pathology, Oslo University Hospital, Oslo, Norway., Skrede ML; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Dalsgaard AM; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Nebdal DJH; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Helland Å; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Lingjærde OC; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Computer Science, University of Oslo, Oslo, Norway., Labori KJ; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Hepato-Pancreato-Biliary Surgery, Oslo University Hospital, Oslo, Norway., Skålhegg BS; Division of Molecular Nutrition, University of Oslo, Oslo, Norway., Lehtiö J; Department of Oncology-Pathology, Karolinska Institutet, Science for Life Laboratory, Solna, Sweden., Kure EH; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Natural Sciences and Environmental Health, University of South-Eastern Norway, Bø i Telemark, Norway.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2022 Jun 14; Vol. 2 (6), pp. 434-446. Date of Electronic Publication: 2022 Jun 14 (Print Publication: 2022).
Autor:
Venizelos A; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Bergen, Norway., Elvebakken H; Department of Oncology, Ålesund Hospital, Møre og Romsdal Hospital Trust, Ålesund, Norway.; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway., Perren A; Institute of Pathology, University of Bern, Bern, Switzerland., Nikolaienko O; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Bergen, Norway., Deng W; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Bergen, Norway., Lothe IMB; Department of Pathology, Oslo University Hospital, Oslo, Norway., Couvelard A; Department of Pathology, Université de Paris, Bichat Hospital, AP-HP, Paris, France., Hjortland GO; Department of Oncology, Oslo University Hospital, Oslo, Norway., Sundlöv A; Departmentt of Oncology, Skåne University Hospital, Lund, Sweden.; Department of Medical Radiation Physics, Lund University, Lund, Sweden., Svensson J; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden., Garresori H; Department of Oncology, Stavanger University Hospital, Stavanger, Norway., Kersten C; Department of Research, Hospital of Southern Norway, Kristiansand, Norway., Hofsli E; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Oncology, St.Olavs Hospital, Trondheim, Norway., Detlefsen S; Department of Pathology, Odense University Hospital, Odense, Denmark.; Department of Clinical Medicine, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark., Krogh M; Department of Oncology, Odense University Hospital, Odense, Denmark., Sorbye H; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway., Knappskog S; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Bergen, Norway.
Publikováno v:
Endocrine-related cancer [Endocr Relat Cancer] 2021 Nov 11; Vol. 29 (1), pp. 1-14. Date of Electronic Publication: 2021 Nov 11.
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke [Tidsskr Nor Laegeforen] 2020 Dec 14; Vol. 140 (18). Date of Electronic Publication: 2020 Dec 14 (Print Publication: 2020).
Autor:
Lu, Kuan-Yu1 (AUTHOR), Tung, Wei-En1 (AUTHOR), Chiang, Chang-Jung1,2 (AUTHOR), Hsieh, Yueh-Ying1,2 (AUTHOR), Chen, Chia-Hsien1,3 (AUTHOR), Lee, Mei-Hui4 (AUTHOR), Yen, Min-Hsuan5 (AUTHOR), Lu, Po-Wen6,7 (AUTHOR), Wu, Lien-Chen1,2,7 (AUTHOR) d98548019@tmu.edu.tw
Publikováno v:
BMC Infectious Diseases. 3/6/2024, Vol. 24 Issue 1, p1-6. 6p.
Autor:
Guren TK; Department of Oncology, Oslo University Hospital, Oslo, Norway.; K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Oslo, Norway., Thomsen M; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Kure EH; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Sorbye H; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway., Glimelius B; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Pfeiffer P; Department of Oncology, Odense University Hospital, Odense, Denmark.; Institute of Clinical Research, University of Southern Denmark, Odense, Denmark., Österlund P; Department of Oncology, Tampere University Hospital, Tampere, Finland., Sigurdsson F; Department of Oncology, Landspitali, Reykjavik, Iceland., Lothe IMB; Department of Pathology, Oslo University Hospital, Oslo, Norway., Dalsgaard AM; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Skovlund E; Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway., Christoffersen T; Department of Pharmacology, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Tveit KM; Department of Oncology, Oslo University Hospital, Oslo, Norway.; K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Publikováno v:
British journal of cancer [Br J Cancer] 2017 May 09; Vol. 116 (10), pp. 1271-1278. Date of Electronic Publication: 2017 Apr 11.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.